Preventing lymphedema through immediate lymphatic reconstruction during surgery
Official title: Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial
Run by M.D. Anderson Cancer Center · NCT06989099 · Data updated 2026-11-12
This study is testing if a new surgery technique called immediate lymphatic reconstruction can help prevent lymphedema in patients with invasive breast cancer after they have lymph nodes removed.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | September 24, 2024 |
| Main results expected | August 1, 2028 |
| Study ends | August 1, 2029 |
| Registry record updated | September 25, 2026 |
| Trial ID | NCT06989099 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are female patients aged 18 and older diagnosed with invasive breast cancer who are scheduled for ILR during their axillary lymphadenectomy.
✕Probably not a fit
Patients who are pregnant, breastfeeding, or have pre-existing lymphedema will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate whether immediate lymphatic reconstruction (ILR) performed during axillary lymphadenectomy can reduce the risk of developing lymphedema in patients diagnosed with invasive breast cancer (IBC). The primary objective is to assess the freedom from lymphedema rate two years post-surgery. Secondary objectives include estimating the persistence of lymphedema at two years, identifying anatomical or functional characteristics that may increase lymphedema risk, and evaluating changes in inflammatory mediators and immune cell function related to lymphedema development.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the incidence of lymphedema in breast cancer patients undergoing surgery.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in reducing lymphedema risk through surgical interventions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Participants diagnosed with IBC. 2. Participants who have been scheduled for ILR/pLVB by their treating physician/surgeon at the time of their axillary lymphadenectomy for breast cancer 3. Participants willing and able to comply with the study protocol requirements and all study-related visit requirements. 4. Female subjects at least 18 years old and capable of providing consent to participate. 5. Females of childbearing potential must have a negative urine pregnancy test within 36 hours prior to study drug administration and agree to use a medically accepted method of contraception for a period of one month following the study. Exclusion Criteria: 1. Patients known to be pregnant or breast-feeding. 2. Patients with known or suspected iodine or ICG hypersensitivity. 3. Patients unable to remain stationary for one hour. 4. Active cellulitis. 5. Subjects with a preoperative clinical lymphedema diagnosis. 6. Subjects undergoing bilateral ALND. 7. Subjects requiring immediate chest wall reconstruction with a pedicled or microvascular flap, or those that have received preoperative radiation therapy. 8. Patients with BMI \>45kg/m2.
Where it's running
-
MD Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Mark Schaverien, MD — M.D. Anderson Cancer Center
- Study coordinator: Sara Hull, MHA, BA, BSN, RN, CCRP
- Email: sehull@mdanderson.org
- Phone: 713-794-1247
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Use of reconstructive microsurgery to treat lymphedema
This study tests whether reconstructive microsurgery, with or without the help of indocyanine green imaging, can help people with lymphedema feel and function better by improving lymphatic drainage.
-
Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis
This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.
-
Boosted compression for lower limb edema
This study tests whether applying a multicomponent short-stretch bandage three times daily (boosted compression) helps reduce edema faster in people with chronic edema or lymphedema of the legs, compared with the standard single daily bandage.
-
Erector Spinae Block vs Paravertebral Block for Chronic Pain After Mastectomy
This trial tests whether an erector spinae block can better prevent chronic pain after mastectomy than a paravertebral block in adults 18–80.
-
Resistance exercise for people with lower-limb lymphedema
This study tests whether short periods of supervised resistance exercise, with and without compression garments, change swelling or symptoms in people with lower-limb lymphedema.
-
Tracking body composition changes after breast cancer treatment
This project will see how muscle mass and fat distribution change over two years in adults treated for stage I–III breast cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.